Article 14 F1
United Kingdom
If the details of the itinerary and means of transport are not provided in the application, the export authorisation shall state that the operator must supply those details to the customs office of exit or other competent authorities at the point of exit from F2Great Britain before the physical departure of the consignment. In such cases the export authorisation shall be annotated accordingly at the time of issue.
F3...
The export authorisation shall be presented to the customs office when the customs declaration is made, or in the absence of a customs declaration, at the customs office of exit or other competent authorities at the point of exit from Great Britain. The authorisation shall accompany the consignment to the third country of destination F4or Northern Ireland.
The customs office of exit or other competent authorities at the point of exit from Great Britain shall insert the necessary details referred to in Article 13(1)(d) in the authorisation and affix its stamp thereon.
Annotations
Textual amendments
- F1
Regulation revoked (N.I.) (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), reg. 1(1), Sch.
- F2
Words in Art. 14(1)(2) substituted (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), regs. 1(1), 6(12)(a)
- F3
Words in Art. 14 omitted (31.12.2020) by virtue of The Law Enforcement and Security (Amendment) (EU Exit) Regulations 2019 (S.I. 2019/742), regs. 1, 14(12)(b); 2020 c. 1, Sch. 5 para. 1(1)
- F4
Words in Art. 14(2) inserted (29.6.2026) by The Controlled Drugs (Drug Precursors) (Amendment and Revocation) Regulations 2026 (S.I. 2026/607), regs. 1(1), 6(12)(b)